Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 9, no: 1 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: A4HZB8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 213 | 217 | PF00656 | 0.568 |
CLV_MEL_PAP_1 | 153 | 159 | PF00089 | 0.543 |
CLV_NRD_NRD_1 | 174 | 176 | PF00675 | 0.640 |
CLV_NRD_NRD_1 | 239 | 241 | PF00675 | 0.570 |
CLV_PCSK_FUR_1 | 47 | 51 | PF00082 | 0.528 |
CLV_PCSK_KEX2_1 | 49 | 51 | PF00082 | 0.543 |
CLV_PCSK_PC1ET2_1 | 49 | 51 | PF00082 | 0.543 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.576 |
CLV_PCSK_SKI1_1 | 280 | 284 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 306 | 310 | PF00082 | 0.389 |
CLV_Separin_Metazoa | 86 | 90 | PF03568 | 0.430 |
DOC_CYCLIN_yCln2_LP_2 | 11 | 17 | PF00134 | 0.576 |
DOC_CYCLIN_yCln2_LP_2 | 112 | 115 | PF00134 | 0.374 |
DOC_MAPK_gen_1 | 104 | 112 | PF00069 | 0.318 |
DOC_MAPK_gen_1 | 49 | 59 | PF00069 | 0.444 |
DOC_MAPK_JIP1_4 | 89 | 95 | PF00069 | 0.411 |
DOC_MAPK_MEF2A_6 | 261 | 268 | PF00069 | 0.422 |
DOC_MAPK_RevD_3 | 34 | 50 | PF00069 | 0.350 |
DOC_PP1_RVXF_1 | 230 | 236 | PF00149 | 0.319 |
DOC_PP2B_LxvP_1 | 112 | 115 | PF13499 | 0.431 |
DOC_PP2B_LxvP_1 | 93 | 96 | PF13499 | 0.477 |
DOC_SPAK_OSR1_1 | 120 | 124 | PF12202 | 0.322 |
DOC_SPAK_OSR1_1 | 156 | 160 | PF12202 | 0.354 |
DOC_USP7_MATH_1 | 138 | 142 | PF00917 | 0.383 |
DOC_WW_Pin1_4 | 115 | 120 | PF00397 | 0.411 |
DOC_WW_Pin1_4 | 254 | 259 | PF00397 | 0.397 |
DOC_WW_Pin1_4 | 26 | 31 | PF00397 | 0.510 |
LIG_14-3-3_CanoR_1 | 156 | 160 | PF00244 | 0.348 |
LIG_14-3-3_CanoR_1 | 232 | 236 | PF00244 | 0.288 |
LIG_14-3-3_CanoR_1 | 280 | 285 | PF00244 | 0.410 |
LIG_14-3-3_CanoR_1 | 53 | 57 | PF00244 | 0.426 |
LIG_Actin_WH2_2 | 123 | 138 | PF00022 | 0.350 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.530 |
LIG_BIR_III_4 | 74 | 78 | PF00653 | 0.405 |
LIG_BRCT_BRCA1_1 | 117 | 121 | PF00533 | 0.393 |
LIG_CSL_BTD_1 | 168 | 171 | PF09270 | 0.315 |
LIG_FHA_1 | 177 | 183 | PF00498 | 0.390 |
LIG_FHA_2 | 81 | 87 | PF00498 | 0.448 |
LIG_LIR_Gen_1 | 55 | 64 | PF02991 | 0.409 |
LIG_LIR_Nem_3 | 166 | 172 | PF02991 | 0.323 |
LIG_LIR_Nem_3 | 234 | 239 | PF02991 | 0.306 |
LIG_LIR_Nem_3 | 55 | 59 | PF02991 | 0.514 |
LIG_REV1ctd_RIR_1 | 234 | 245 | PF16727 | 0.327 |
LIG_SH2_STAP1 | 178 | 182 | PF00017 | 0.375 |
LIG_SH2_STAT3 | 178 | 181 | PF00017 | 0.343 |
LIG_SH2_STAT5 | 178 | 181 | PF00017 | 0.463 |
LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.283 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.340 |
LIG_SH3_2 | 275 | 280 | PF14604 | 0.431 |
LIG_SH3_3 | 272 | 278 | PF00018 | 0.485 |
LIG_SH3_3 | 297 | 303 | PF00018 | 0.410 |
LIG_SH3_3 | 84 | 90 | PF00018 | 0.435 |
LIG_Sin3_3 | 287 | 294 | PF02671 | 0.355 |
LIG_SUMO_SIM_anti_2 | 286 | 293 | PF11976 | 0.298 |
LIG_TRAF2_1 | 141 | 144 | PF00917 | 0.417 |
LIG_WRC_WIRS_1 | 247 | 252 | PF05994 | 0.321 |
MOD_CDK_SPK_2 | 115 | 120 | PF00069 | 0.412 |
MOD_CDK_SPxxK_3 | 254 | 261 | PF00069 | 0.341 |
MOD_CK1_1 | 180 | 186 | PF00069 | 0.455 |
MOD_CK1_1 | 231 | 237 | PF00069 | 0.347 |
MOD_CK1_1 | 26 | 32 | PF00069 | 0.468 |
MOD_CK1_1 | 293 | 299 | PF00069 | 0.343 |
MOD_CK1_1 | 304 | 310 | PF00069 | 0.574 |
MOD_CK1_1 | 55 | 61 | PF00069 | 0.391 |
MOD_CK2_1 | 138 | 144 | PF00069 | 0.398 |
MOD_CK2_1 | 80 | 86 | PF00069 | 0.451 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.769 |
MOD_GlcNHglycan | 285 | 288 | PF01048 | 0.371 |
MOD_GSK3_1 | 176 | 183 | PF00069 | 0.364 |
MOD_GSK3_1 | 94 | 101 | PF00069 | 0.487 |
MOD_N-GLC_1 | 131 | 136 | PF02516 | 0.556 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.354 |
MOD_NEK2_1 | 182 | 187 | PF00069 | 0.458 |
MOD_NEK2_1 | 215 | 220 | PF00069 | 0.452 |
MOD_NEK2_1 | 309 | 314 | PF00069 | 0.710 |
MOD_NEK2_1 | 98 | 103 | PF00069 | 0.487 |
MOD_NEK2_2 | 131 | 136 | PF00069 | 0.402 |
MOD_PIKK_1 | 177 | 183 | PF00454 | 0.330 |
MOD_PIKK_1 | 309 | 315 | PF00454 | 0.640 |
MOD_PK_1 | 28 | 34 | PF00069 | 0.419 |
MOD_PKA_1 | 176 | 182 | PF00069 | 0.424 |
MOD_PKA_2 | 155 | 161 | PF00069 | 0.397 |
MOD_PKA_2 | 231 | 237 | PF00069 | 0.287 |
MOD_PKA_2 | 52 | 58 | PF00069 | 0.459 |
MOD_Plk_1 | 131 | 137 | PF00069 | 0.400 |
MOD_Plk_1 | 143 | 149 | PF00069 | 0.442 |
MOD_Plk_1 | 165 | 171 | PF00069 | 0.411 |
MOD_Plk_4 | 125 | 131 | PF00069 | 0.379 |
MOD_Plk_4 | 165 | 171 | PF00069 | 0.377 |
MOD_Plk_4 | 231 | 237 | PF00069 | 0.359 |
MOD_Plk_4 | 290 | 296 | PF00069 | 0.349 |
MOD_Plk_4 | 52 | 58 | PF00069 | 0.507 |
MOD_ProDKin_1 | 115 | 121 | PF00069 | 0.407 |
MOD_ProDKin_1 | 254 | 260 | PF00069 | 0.397 |
MOD_ProDKin_1 | 26 | 32 | PF00069 | 0.506 |
MOD_SUMO_rev_2 | 257 | 262 | PF00179 | 0.340 |
TRG_DiLeu_BaLyEn_6 | 108 | 113 | PF01217 | 0.349 |
TRG_NES_CRM1_1 | 243 | 255 | PF08389 | 0.322 |
TRG_Pf-PMV_PEXEL_1 | 161 | 166 | PF00026 | 0.614 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8H6 | Leptomonas seymouri | 50% | 90% |
A0A1X0NXE2 | Trypanosomatidae | 29% | 100% |
A0A3S5IR94 | Trypanosoma rangeli | 32% | 100% |
A0A3S7WWC8 | Leishmania donovani | 100% | 100% |
A4HBM9 | Leishmania braziliensis | 76% | 100% |
D0A1M6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 100% |
E9AUZ8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q4QCI4 | Leishmania major | 93% | 100% |
V5B0L2 | Trypanosoma cruzi | 28% | 100% |